Jean DePamphilis

Efficacy and Safety of Pegylated (40–Kd) Interferon α–2A Compared With Interferon α–2A in Noncirrhotic Patients With Chronic Hepatitis C

K. Rajender Reddy, Teresa L. Wright, Paul J. Pockros et al. · Hepatology · 2001 · 360 citations

Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy

Stefan Mauss, William M. Valenti, Jean DePamphilis et al. · AIDS · 2004 · 157 citations

Impact of High-Dose Peginterferon Alfa-2A on Virological Response Rates in Patients with Hepatitis C Genotype 1: a Randomized Controlled Trial† ‡

Stuart K. Roberts, Martin Weltman, Dorothy H. Crawford et al. · Hepatology · 2009 · 64 citations · Full text

Effect of Baseline CD4 Cell Count on the Efficacy and Safety of Peginterferon Alfa-2a (40KD) Plus Ribavirin in Patients With HIV/Hepatitis C Virus Coinfection

Milos Opravil, Joe Sasadeusz, David A. Cooper et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2008 · 63 citations

Histological response to pegIFNα-2a (40KD) plus ribavirin in HIV–hepatitis C virus co-infection

Eduardo Lissen, Nathan Clumeck, R. Solà et al. · AIDS · 2006 · 50 citations